Last reviewed · How we verify

NCT06609018

Clinical Investigation of Buttermere (LENS 271) Soft Contact Lenses

Completed NA Last updated 24 February 2026
What this trial tests

NA trial testing Test Lenses (stenfilcon A) in Myopia in 73 participants. Completed in 5 March 2025.

Timeline
1 August 2024
Primary endpoint
5 March 2025
5 March 2025

Quick facts

Lead sponsorCooperVision, Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment73
Start date1 August 2024
Primary completion5 March 2025
Estimated completion5 March 2025
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

CooperVision, Inc.

Who can join

Adults 8 to 18, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to compare clinical performance between two soft contact lenses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Test Lenses (stenfilcon A)

Trials testing the same drug.

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other CooperVision, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06609018.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing